Stefan Lorenzl, MD

Affiliations: 
Neurology Ludwig-Maximilians-Universität München, München, Bayern, Germany 
Google:
"Stefan Lorenzl"
Mean distance: 17.48 (cluster 28)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Nuebling G, Hensler M, Paul S, et al. (2016) PROSPERA: a randomized, controlled trial evaluating rasagiline in progressive supranuclear palsy. Journal of Neurology
Levin J, Maaß S, Schuberth M, et al. (2016) The PROMESA-protocol: progression rate of multiple system atrophy under EGCG supplementation as anti-aggregation-approach. Journal of Neural Transmission (Vienna, Austria : 1996)
Oliver DJ, Borasio GD, Caraceni A, et al. (2015) A consensus review on the development of palliative care for patients with chronic and progressive neurological disease. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies
Levin J, Bak TH, Rominger A, et al. (2015) The association of aphasia and right-sided motor impairment in corticobasal syndrome. Journal of Neurology. 262: 2241-6
Sieb JP, Themann P, Warnecke T, et al. (2015) Caregivers' and physicians' attitudes to rotigotine transdermal patch versus oral Parkinson's disease medication: an observational study. Current Medical Research and Opinion. 31: 967-74
Huemer M, Bürer C, Ješina P, et al. (2014) Clinical onset and course, response to treatment and outcome in 24 patients with the cblE or cblG remethylation defect complemented by genetic and in vitro enzyme study data. Journal of Inherited Metabolic Disease
Rémi C, Lorenzl S, Vyhnalek B, et al. (2014) Continuous subcutaneous use of levetiracetam: a retrospective review of tolerability and clinical effects. Journal of Pain & Palliative Care Pharmacotherapy. 28: 371-7
Bükki J, Unterpaul T, Nübling G, et al. (2014) Decision making at the end of life--cancer patients' and their caregivers' views on artificial nutrition and hydration. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. 22: 3287-99
Nübling GS, Levin J, Bader B, et al. (2014) Modelling Ser129 phosphorylation inhibits membrane binding of pore-forming alpha-synuclein oligomers. Plos One. 9: e98906
Boxer AL, Lang AE, Grossman M, et al. (2014) Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial. The Lancet. Neurology. 13: 676-85
See more...